Abstract:The glucose transporter family (GLUT) consists of fourteen members. It is responsible for glucose homeostasis and glucose transport from the extracellular space to the cell cytoplasm to further cascade catalysis. GLUT proteins are encoded by the solute carrier family 2 (SLC2) genes and are members of the major facilitator superfamily of membrane transporters. Moreover, different GLUTs also have their transporter kinetics and distribution, so each GLUT member has its uniqueness and importance to play essential roles in human physiology. Evidence from many studies in the field of diabetes showed that GLUT4 travels between the plasma membrane and intracellular vesicles (GLUT4-storage vesicles, GSVs) and that the PI3K/Akt pathway regulates this activity in an insulin-dependent manner or by the AMPK pathway in response to muscle contraction. Moreover, some published results also pointed out that GLUT4 mediates insulin-dependent glucose uptake. Thus, dysfunction of GLUT4 can induce insulin resistance, metabolic reprogramming in diverse chronic diseases, inflammation, and cancer. In addition to the relationship between GLUT4 and insulin response, recent studies also referred to the potential upstream transcription factors that can bind to the promoter region of GLUT4 to regulating downstream signals. Combined all of the evidence, we conclude that GLUT4 has shown valuable unknown functions and is of clinical significance in cancers, which deserves our in-depth discussion and design compounds by structure basis to achieve therapeutic effects. Thus, we intend to write up a most updated review manuscript to include the most recent and critical research findings elucidating how and why GLUT4 plays an essential role in carcinogenesis, which may have broad interests and impacts on this field.

The Vesicle Traffic and Related Clinical Diseases of Glucose Transporter 4

Research on the Dynamics Effects of Autophagy on GLUT4

Effects of High Glucose on the Activity of GSH-PX,the Expressions of NOS and ICAM-1 in Human Umbilical Vein Endothelial Cells

Glucose transporter 4: Insulin response mastermind, glycolysis catalyst and treatment direction for cancer progression

Research Progress on Vesicular Trafficking in Amyotrophic Lateral Sclerosis.

Update on GLUT4 Vesicle Traffic: A Cornerstone of Insulin Action

Roles of GLUT-1 and HK-II Expression in the Biological Behavior of Head and Neck Cancer

A Pre-Docking Role for Microtubules in Insulin-Stimulated Glucose Transporter 4 Translocation.

Bi-directional transport of GLUT4 vesicles near the plasma membrane of primary rat adipocytes.

Role of Rab proteins in glucose transporter 4 translocation:research advances

Relationship of Glucose Transporter 1 and Malignant Tumor: an Advance

Facilitative glucose transporters:expression,distribution and the relationship to diseases

GLUT1: a Promising Drug Target for Cancer Treatment

Glucose Transporter 1, Distribution in the Brain and in Neural Disorders: Its Relationship with Transport of Neuroactive Drugs Through the Blood-Brain Barrier

Relationship Between GLUT-1 and Tumor

The Regulatory Role of Phosphatidylinositol Signaling in GLUT4 Vesicle Trafficking

Spatiotemporal Regulators for Insulin-Stimulated GLUT4 Vesicle Exocytosis

Molecular Insights into the Glucose Transporter GLUT5

Characterization of GLUT4-containing Vesicles in 3T3-L1 Adipocytes by Total Internal Reflection Fluorescence Microscopy

[Relationships of glucose transporter 4 with cognitive changes induced by high fat diet and glucose metabolism in hippocampus]

Dynamic tracking and mobility analysis of single GLUT4 storage vesicle in live 3T3-L1 cells